Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association

By sjmartinez • January 29, 2025

Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA. Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association. Clin Infect Dis. 2025 Jan 28:ciae648. doi: 10.1093/cid/ciae648. Epub ahead of print. PMID: 39873495.

Tags: antiretroviral agents, Cabotegravir, Health policy, Infectious Diseases, lenacapavir, Pre-exposure prophylaxis, Publications

Envisioning a Multidisciplinary HBV Cure Research Agenda

Dubé K, Ahmed A, Cohen C, Ibrahim Y, Yendewa GA, Cachay ER, Wang S, Marks K, Kim AY, Sugarman J, Thomas DL, Thio CL, Bhattacharya[...]

Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083

Hanscom B, Marzinke MA, Li X, Donnell D, Bies R, Hendrix CW, Wang Z, Acuipil C, Rinehart A, Collins JW, Rooney JF, Soto Torres L,[...]

Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in Los Angeles County

Lee PS, OYong K, Shah AN, Thiel C, LeBrun M, Miller LG, Rubin Z. Environmental and human health impact of contact precaution use for methicillin-resistant Staphylococcus[...]